Abstract

In search of new potent molecules against tuberculosis, 3,4-dihydro-2(1H)-quinolinone based 1,2,3-triazoles were synthesized efficiently by means of click chemistry and their structures were confirmed by spectral data. Among the synthesized twelve novel molecules, seven are hybrid of 3,4-dihydro-2(1H)-quinolinone, 1,2,3–1H-triazole nucleus with different coumarin derivatives and in remaining molecules coumarin is replaced by alkyl, aryl, and pyranose derivatives. Among the synthesized compounds, eight were screened for anti-TB activity against H37Rv strain and found to have good inhibition activity with lower MIC values (2.7–10.6 µM). Compound 6 h with (6-(acetoxymethyl)tetrahydro-2H-pyran-2,4,5-triyl triacetate) substitution is most active against MTB. Further their antioxidant activity was assessed using DPPH assay and the compounds have shown moderate to low activity compared to standard ascorbic acid. The cytotoxicity of the synthesised compounds against lung cancer cell lines exhibited good to moderate activity and do not induce significant toxicity. In Superoxide dismutase(SOD) enzyme activity studies some of the compounds exhibited promising activity. The interactions of the molecules were studied against DprE1 protein of MTB through molecular docking.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.